| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2971812 | The Journal of Heart and Lung Transplantation | 2010 | 6 Pages |
Abstract
VAD therapy successfully decreases pulmonary hypertension, even in patients with “fixed” FPH, allowing candidacy for heart transplantation. Among bridge-to-transplant candidates, the presence of FPH does not reduce post-transplant survival.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ana Carolina MD, Vivek MD, PhD, Heather J. MD, MHSc, Annette S. MD, Kaare MD, DMSc, Finn MD, PhD, Diego H. MD,